Shawver Laura is a corporate insider at ARS Pharmaceuticals, Inc. (SPRY) filing SEC Form 4 transactions. 118 transactions across 5 companies, totaling $0 in purchases and $8,625,197 in sales. Source: SEC EDGAR.
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 30,000 | - | - | 30,000 | 6/25/2025 Filed: 6/27/2025 | Filing → | |
| Exercise | 27,493 | - | - | 24,062 | 4/7/2025 Filed: 4/8/2025 | Filing → | |
| Exercise | 22,509 | - | - | 51,555 | 4/7/2025 Filed: 4/8/2025 | Filing → | |
| Sale | 50,002 | $12.30 | $615K | 210,346 | 4/7/2025 Filed: 4/8/2025 | Filing → | |
| Exercise | 27,493 | $4.85 | $133K | 260,348 | 4/7/2025 Filed: 4/8/2025 | Filing → | |
| Exercise | 22,509 | $4.85 | $109K | 232,855 | 4/7/2025 Filed: 4/8/2025 | Filing → | |
| Exercise | 49,600 | $4.85 | $241K | 74,064 | 3/6/2025 Filed: 3/7/2025 | Filing → | |
| Sale | 49,600 | $11.21 | $556K | 210,346 | 3/6/2025 Filed: 3/7/2025 | Filing → | |
| Exercise | 49,600 | $4.85 | $241K | 259,946 | 3/6/2025 Filed: 3/7/2025 | Filing → | |
| Exercise | 400 | $4.85 | $2K | 123,664 | 3/5/2025 Filed: 3/7/2025 | Filing → | |
| Sale | 400 | $11.00 | $4K | 210,346 | 3/5/2025 Filed: 3/7/2025 | Filing → | |
| Exercise | 400 | $4.85 | $2K | 210,746 | 3/5/2025 Filed: 3/7/2025 | Filing → | |
| Exercise | 40,936 | $4.85 | $199K | 124,064 | 2/3/2025 Filed: 2/4/2025 | Filing → | |
| Exercise | 9,064 | $3.15 | $29K | 0 | 2/3/2025 Filed: 2/4/2025 | Filing → | |
| Sale | 50,000 | $12.31 | $616K | 210,346 | 2/3/2025 Filed: 2/4/2025 | Filing → | |
| Exercise | 40,936 | $4.85 | $199K | 260,346 | 2/3/2025 Filed: 2/4/2025 | Filing → | |
| Exercise | 9,064 | $3.15 | $29K | 219,410 | 2/3/2025 Filed: 2/4/2025 | Filing → | |
| Exercise | 50,000 | $3.15 | $158K | 9,064 | 1/6/2025 Filed: 1/7/2025 | Filing → | |
| Sale | 50,000 | $11.10 | $555K | 210,346 | 1/6/2025 Filed: 1/7/2025 | Filing → | |
| Exercise | 50,000 | $3.15 | $158K | 260,346 | 1/6/2025 Filed: 1/7/2025 | Filing → |
Try asking...